一天服用"多种维生素"会让"MASLD医生"远离吗?
Fernando Bril1,2,3
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Metabolism and target organ damage
|November 3, 2025
概括
这项研究探讨了在代谢功能障碍相关的脂肪性肝病 (MASLD) 中的同型半氨酸代谢. 数学建模表明,辅因子替代可能会影响同类氨酸水平,可能会影响MASLD治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 生物化学 生物化学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题.
- 人们越来越认识到同类氨酸代谢是导致肝病进展的一个因素.
- 了解同类氨酸和MASLD严重程度之间的相互作用对于治疗开发至关重要.
研究的目的:
- 分析同类氨酸代谢和MASLD的组织学严重程度之间的关系.
- 模拟辅因子替代 (皮里多克素,科巴胺,贝他因,叶酸) 对MASLD患者的同类半氨酸水平的潜在影响.
- 讨论这些关联的临床和病理生理学影响.
主要方法:
- 对一项评估同类氨酸水平和MASLD组织学严重程度的研究的审查和评论.
- 应用数学模型来模拟对同类半氨酸的辅因子替代效应.
- 对现有文献进行分析,以提供病理生理学支持.
主要成果:
- 观察到同类氨酸代谢和MASLD组织学严重程度之间存在相关性.
- 数学建模表明,辅助因子补充可能会调节MASLD中的同类半氨酸水平.
- 这项研究强调了需要进一步调查同类半氨酸在MASLD中的作用.
结论:
- 通过辅因子替代来调节同型半氨酸水平可能是MASLD的潜在治疗途径.
- 需要进一步的纵向和干预研究来验证这一策略.
- 这些发现强调了新陈代谢功能障碍,同氨酸和肝脏疾病之间的复杂关系.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
206
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
206
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
209
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
209
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
245
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
245
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:16Hepatic Drug Excretion: Influencing Factors
516
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
516